The 1st Patient Sarcoidosis Conference was held in UM. Dr. Forghani, Dr. Diana Laura, and Dr. Mirsaeidi discussed different clinical presentations of sarcoidosis and application of pharmacogenetics in sarcoidosis.
Afternoon, attendees discussed the critical lack of knowledge on sarcoidosis in community
and potential ways to improve it.
A new sarcoidosis patient support group has been formed and will be support south Florida sarcoidosis patients.
NEW: COVID-19 infection and Sarcoidosis - What do our patients need to know?(spanish version available).
UM Sarcoidosis Program recently launched a new App for management of sarcoidosis. Learn more about it in the section of "For Physicians" on this page.
Our Scientific research philosophy is to answer all unanswered questions on diagnosis, treatment and prognosis about sarcoidosis. Anyone with an interest in sarcoidosis can join and take part in our activities. For more information about joining the current studies please contact us.
Dr. Mehdi Mirsaeidi at email@example.com
Our new Artificial Intelligence tool for patients with sarcoidosis. click here for access.
University of Miami Sarcoidosis Center of Excellence is recognized by the World Association for Sarcoidosis and Other Granulomatous Diseases (WASOG). This designation provides formal recognition of our team’s commitment to deliver high quality of care and remarkable contribution to the field of granulomatous diseases.
Currently, our Center is developing and validating molecular diagnostic tests to personalized Sarcoidosis treatment. The Program is also working in the discovery and implementation of companion components to improve treatment outcome. We are proud to announce that, in collaboration with Dr. Irman Forghani from UM Department of Medical Genetics, our patients would be tested for pharmacogenetics.
Lean more about our research projects in our Research section. We are happy to partner with other centers worldwide for the advancement of Sarcoidosis Research.